Skip to content
Catalyst

PapersPMID:40089929

Salvia miltiorrhiza adjuvant therapy facilitates cardiac function recovery in patients with myocardial infarction.

Pakistan journal of pharmaceutical sciences2025The record ↗

  1. Finding, very limited evidenceraisesLeft ventricular ejection fraction

What moved

1 findingHow to read these marks →
  • “After two weeks, the SM group demonstrated significantly increased left ventricular ejection fraction (LVEF) and reduced left ventricular end-systolic and end-diastolic diameters (LVESD, LVEDD) compared to RT (P<0.001).”
    Study
    RCT
    Dose studied
    Salvia miltiorrhiza injection added to routine treatment; dose and route not stated in the abstract
    Population
    120 patients with acute myocardial infarction; both arms received routine treatment (RT), the intervention arm had Salvia miltiorrhiza injection added

Study record

Design
randomised controlled trial
Species
human
Population
Patients with acute myocardial infarction; abstract only; Salvia miltiorrhiza (SM) injection added to routine treatment (RT) versus RT alone
Participants
120
Comparator
no treatment / not stated in the paper
Duration
not reported
Endpoints measured
8